The erythroid differentiation-inducing effect of apigenin and its derivatives on human chronic myeloid leukemia K562 has been reported but the functional group in its structure responsible for the effect has not yet been elucidated. Here, we determined the moiety responsible for the erythroid differentiation induction effect of apigenin by using different flavonoids to represent the functional groups in its structure. In addition, we compared apigenin and apigetrin, a flavonoid similar in structure to apigenin except for the glycoside in its structure. Morphological changes as well as expressions of specific markers in K562 cells treated with apigenin were compared with those treated with apigetrin, flavone, 7-hydroxyflavone, chrysin, luteolin, or naringenin. The anti-proliferative and erythroid differentiation-inducing effect of apigenin and the five flavonoids were then investigated and their effects on the a, b, and c globin genes expressions were compared using real-time PCR. Results of the comparison between apigenin and apigetrin revealed that the glycoside part of apigetrin does not have a role in the induction of cell differentiation. Based on glycophorin A expression, the potency of the other flavonoids for induction of differentiation, was: apigenin > chrysin > flavone/7-hydroxyflavone > luteolin/naringenin. Results of the analysis of the relationship between the structure and function of the flavonoids suggest that the apigenin-induced K562 cell differentiation was due to the 2-3 double bond and hydroxyl groups in its structure. This is the first study that identified the specific functional group in apigenin that impact the erythroid differentiation effect in K562 cells.
Introduction
Plant bioactive compounds have great potential role in the prevention or cure of diseases. Recently, the beneficial effects of phytochemicals from fruits, vegetables, grains and herbal medicine on human health has gained a major interest [1] . At present, more than 8000 different polyphenolic compounds are known, the most abundant phytochemicals are flavonoids constituting of more than 4000 compounds [2] . Flavonoids have various benefits for human health due to its anti-oxidant and free-radical scavenger activities as well as anti-inflammatory, antiviral, and anti-cancer properties [3, 4] . The flavonoid's structure consists of two aromatic rings (ring A and ring B) linked by three carbons representing the C ring. Variations in the heterocycle (ring C) define the different subclasses of flavonoids. The compounds in each subclass are defined by their hydroxylation and conjugation patterns. Flavonoids are frequently found in nature in the glycosylated or esterified forms [5] .
Apigenin is recognized as a bioactive flavonoid shown to possess anti-inflammatory, antioxidant. The inhibitory effect of apigenin against UVB-induced cyclooxygenase-2 (COX-2) expression in keratinocyte [6] , TNFa-induced NF-kB transcription activation, and chemokine expressions [7] have been reported. In addition, apigenin also inhibits whole body gamma (c)-irradiation, oxidative damage and hematological alterations in Swiss albino mice. [8] . Apigenin has also been shown to possess growth inhibitory properties in several cancer lines, including breast, colon, skin, thyroid, and leukemia cells [9] [10] [11] [12] [13] . In our previous study, we provided additional evidence to the fact that flavonoids are potent inducers of leukemia cell differentiation and demonstrated that the flavonoid apigenin-7-glycoside ( Fig. 1) can induce acute myeloid leukemia HL-60 cells and chronic myeloid leukemia K562 cells to differentiate to the granulocytic and the erythrocytic lineages, respectively [14, 15] . The characteristic feature of hematological cancer cells is the observed inhibition of cell differentiation at a particular stage in its maturation. During the past three decades, a new concept of treating leukemia that forces the malignant cells to undergo terminal differentiation instead of induction of cell death, referred to as ''differentiation therapy'' has been developed [16] . Although studies on the relationship between the chemical structure of flavonoids and their anti-leukemia effect have already been reported, most of these studies were on the flavonoids' antiproliferative and the apoptosis-inducing activities [17, 18] . It has been established that the effectiveness of flavonoids as therapeutics is dependent on their specific structural characteristics [13, 19, 20] . Here, we characterized the differentiation-induction effect of apigenin ( Fig. 1 ) on K562 cells and revealed which functional group in its chemical structure is responsible for anti proliferative effect and/or including cell arrest.
Materials and methods

Cell line and culture conditions
Human chronic leukemia cell line K562 was obtained from the Riken cell bank (Tsukuba, Ibaraki, Japan). Cells were cultured in RPMI 1640 medium (Gibco), supplemented with 10% heat-inactivated fetal bovine serum and maintained at 37°C in a humidified incubator with 5% CO 2 . The cells were pass-cultured every 3 days and used for experiments after reaching the exponential growth phase.
Chemicals used for cell treatment
Apigenin, apigetrin, and naringenin were purchased from Sigma Aldrich (St. Louis, MO), luteolin from Wako Pure Chemical Industries, Ltd. of Japan while flavone and 7-hydroxyflavone were obtained from Tokyo Chemical Industry Co., Ltd of Japan. Each sample was dissolved in dimethylsulfoxide (DMSO) (Wako, Japan) and stored at À20°C. Treatment of cells was carried out by diluting the stock solution in culture medium immediately before use.
Cytosine arabinoside (Ara-C) at 25 lM was used as positive control for erythrocyte differentiation.
MTT assay
The effect of apigenin, apigetrin, flavone, 7-hydroxyflavone, chrysin, luteolin or naringenin (25, 50 , or 100 lM) on the proliferation of K562 cells was investigated using the MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. K562 cells were seeded into 96-well plates at 2 Â 10 3 cells per well. After incubation for 24 h, the flavonoids were added at a final concentration of 50 lM. Control cells were treated with DMSO (0.1%). MTT was added after 72 h of incubation and the resulting formazan was completely dissolved in 100 lL of 10% sodium dodecyl sulfate (SDS). The absorbance was determined at 570 nm in a multidetection microplate reader (Power-scan HT, Dainippon Pharmaceutical, NJ, USA).
Cell viability assay and cell morphological changes
The viability of K562 cells treated with of apigenin, apigetrin, flavone, 7-hydroxyflavone, chrysin, luteolin, or naringenin was measured using Countess automatic cell counter (Invitrogen, Carlsbad, CA). Briefly, cells were seeded into 100-mm culture dishes at 2 Â 10 4 cells/mL and treated with 50 lM of each flavonoid for the indicated incubation times. After collecting and staining the cells with trypan blue, of the viable and non-viable cell counts were calculated using Countess Automated Cell Counter (Invitrogen). Morphological changes were observed using a phase contrast microscope (Leica Microsystems, Wetzlar, Germany).
Glycophorin A expression assay
The determination of which part of the apigenin structure imparts the erythroid differentiation effect was assessed by measuring the expression of glycophorin A, using a flow cytometer (Guava Technologies, Inc.), on the surface of K562 cells treated with representative flavonoids apigetrin, flavone, 7-hydroxyflavone, chrysin, luteolin or naringenin. Cells were seeded at 2 Â 10 4 cells/ mL in 100-mm culture dishes and incubated for 24 h at 37°C in a humidified 5% CO 2 incubator prior to treatment with each flavonoid (at 50 lM concentration). Cells were then incubated for 3-6 days, changing the medium after 3 days of incubation. Cells were then harvested and the cell count adjusted to 1 Â 10 5 cells/mL. After washing with PBS, cells were labeled with PE-conjugated antiglycophorin A for 30 min according to manufacturer's instructions.
Cells were washed twice with PBS and resuspended in 500 lL PBS prior to measurement of glycophorin A expression.
2.6. Expressions of a-globin, b-globin and c-globin mRNA Quantitative real-time PCR using specific primers for a-globin, b-globin or c-globin was carried out to evaluate the expressions of a-globin, b-globin and c-globin in K562 cells treated with or without apigenin, apigetrin, flavone, 7-hydroxyflavone, chrysin, luteolin, or naringenin. After seeding 2 Â 10 4 K562 cells/mL in 100-mm cell culture dishes and incubating them for 24 h, each compound was added to a final concentration of 50 lM. DNA-free total RNA was isolated using Isogen (Nippongene, Tokyo, Japan) following the manufacturer's instructions. Isolated RNA was quantified using a Nanodrop 2000 (Themo Scientific, Wilmington, DE) and 1 lg of which was used as a template for cDNA synthesis done using a thermal cycler (Applied Biosystems). Real-time PCR was performed on the Applied Biosystems 7500 Real-Time PCR System, using TaqMan Ò probe-based detection (Applied Biosystems). The Assay ID of the primers (Applied Biosystems) used for RT-PCR are the following: Hs00361191_g1 for Alpha-Globin, Hs00758889_s1 for Beta-Globin, Hs00361131_g1 for Gamma-Globin. The expressions of the globins' mRNA were determined and normalized to the internal control (b-actin) mRNA levels.
Statistical analysis
The differences between the means of the effect of the samples on hemoglobin genes' expressions were analyzed using js-STAR 2012 Software and Bonferroni multiple comparison tests [21] . In other assays, the mean value ± SD and the differences between treated and control treatments were evaluated for significance using the Student's t-test. Differences between the means at the 5% confidence level were considered significant. 
Results
Effect of glucose moiety on induction erythroid differentiation (apigenin vs apigetrin)
The expression of glycophorin A in K562 cells, treated with different concentrations of apigenin, was assessed. Results showed that 50 lM apigenin had the highest differentiation induction effect at 31.6% after 6 days of treatment (Fig. 2a) . To confirm the erythroid differentiation of K562 cells, the expression levels of a-, b-, and c-hemoglobin genes, especially the a-and c-hemoglobins, were increased by treatment with apigetrin, in a time-dependent manner (Fig. 2b) .
The erythroid differentiation induction effect of apigenin and apigetrin was then compared to investigate the role of the sugar moiety present in apigetrin but not in apigenin. Cells treated with 50 lM apigenin or 75 lM apigetrin for 3 days had similar morphology and appeared to be bigger in size compared to the control or untreated cells (Fig. 3a) . Results of the differentiation assay revealed that cells treated with apigenin or apigetrin expressed about the same level of glycophorin A at 17.5% and 16.4%, respectively (Fig. 3b) . These results were corroborated by the levels of a, b, and c hemoglobin mRNA expressions in cells treated with apigenin or apigetrin. In addition, the quantity of globin mRNA in K562 cells, treated with 50 lM apigenin or 75 lM apigetrin was the same (Fig. 3c) . These results establish that the glycoside moeity in the structure of apigetrin is not involved in the induction of erythroid differentiation.
Anti-proliferative effect of apigenin on K562 cells
Five flavonoids that are structural analogs to the functional groups in the apigenin structure were chosen to represent the functional groups in the apigenin structure to investigate which moiety is responsible for the erythroid differentiation effect (Fig. 4) . These flavonoids (apigenin, flavone, 7-hydroxyflavone, chrysin, luteolin and naringenin) differ in the number and position of hydroxyl group in their flavonoid backbone. To evaluate the effect of these flavonoids on cell proliferation, K562 cells treated with 25, 50, or 100 lM of the flavonoids, incubated for 72 h, and subjected to MTT assay. Results showed that all the flavonoids, except naringenin, decreased the proliferation of K562 cells in a dose-dependent manner (Fig. 5a) . Moreover, the anti-proliferative effect of apigenin, flavone and luteolin was greater than those of chrysin and 7-hydroxyflavone. To find out if the anti-proliferative effect of apigenin was an indication of cell death or growth inhibition, we counted K562 cells following treatment with the different flavonoids using trypan blue exclusion method. K562 cells treated with apigenin, flavone, 7-hydroxyflavone, chrysin, or luteolin at different treatment concentrations were significantly less than the control (untreated), while the number of naringenin-treated cells remained the same as the control cells (data not shown). The number of K562 cells when treated with apigenin, flavone and luteolin was less than the 7-hydroxyflavone-and chrysin-treated cells. However, although the number of cells were lower compared to the untreated cells, the viability of cells treated with the different flavonoids, at all the treatment concentrations, remained P80% except for those treated with 100 lM apigenin, flavone or luteolin, or cells treated with 50 lM luteolin (Fig. 5b) , suggesting the occurrence of cell cycle arrest. These results confirmed previous reports that apigenin, flavone, 7-hydroxyflavone and chrysin at 50 lM concentration has an anti-proliferative effect on K562 by arresting cell growth. Changes in the morphology of K562 cells, characterized by an increase in cell size, were also observed following treatment with the different flavonoids especially in cells treated with apigenin, flavone, chrysin or luteolin. No remarkable changes were observed in the naringenin-or 7-hydroxyflavonetreated cells (Fig. 6) . The morphological changes observed correlate with the compounds' cell differentiation effects based on the glycophorin A assay (Fig. 7) .
Glycophorin A expression in K562 cells
Ara-C was used as a positive control for erythroid differentiation and increase in cell size and cessation of cell proliferation has been observed in Ara-C-and c-irradiation-treated K562 cells that underwent erythroid differentiation [22] . Here, microscopic observations also showed morphological changes in K562 cells treated with Ara-C or apigenin, and these morphological changes were observed alongside erythroid differentiation, to evaluate the ability of the flavonoids to induce erythroid differentiation in K562 cells, the expression of glycophorin A, a specific erythrocyte marker, was determined by flow cytometry. K562 cells were treated with 50 lM of each flavonoid or Ara-C, and incubated for 5 days. Significant erythroid differentiation effect was caused by apigenin (31.04 ± 6.4%), chrysin (27.7 ± 3.7%), flavone (18.3 ± 3.4%) and 7-hydroxyflavone (19.5 ± 2.9%). Luteolin and naringenin effected the lowest percentages of differentiation and that were not significantly different from the control cells (10.4 ± 4.0 and 7.1 ± 1.7%, respectively) (Fig. 7) .
Apigenin-induced expressions of a, b, and c globin genes
Erythroid differentiation is accompanied by the synthesis of hemoglobin proteins that characterize erythrocytes. To validate the erythroid differentiation induction effects of the flavonoids, the expressions of a-hemoglobin, b-hemoglobin and c-hemoglobin mRNA in K562 cells were quantified. Results showed that compared to the control, a and c hemoglobin mRNA expressions were increased by 9.3-fold and 4.4-fold, respectively, by apigenin (Fig. 8) . Chrysin also remarkably upregulated a and c mRNA expressions by 5 and 2.9-fold, respectively. A slight increase in the expressions of the mRNA levels was also detected in flavoneand 7-hydroxyflavone-treated K562 cells. Luteolin and naringenin had no significant effect on the expressions of globin genes.
Discussion
Epidemiologic studies considerably support the notion that diets rich in plant flavonoids are associated with a number of beneficial effects that include anti-carcinogenic activities [23] [24] [25] . Apigenin's anti-cancer effect has been well-studied but the determination of the specific functional group in its structure that causes this effect has not yet been done. Here, the effect of apigenin on erythroid differentiation of K562 cells was determined and the functional group in its structure responsible for the observed effect was elucidated.
We have previously reported that apigetrin, a glycoside form of apigenin, induces HL-60 and K562 cells to differentiate into granulocytes and erythrocytes, respectively [11, 12] . Considering the similarity in the chemical structure of apigenin and apigetrin with glucose at R7 position in apigetrin (Fig. 1) , it can be assumed that if both compounds can induce erythroid differentiation, the glucose moiety does not have any role in erythroid differentiation induction. Determination of the expression of glycophorin showed that apigenin-treated cells differentiated into erythrocytes after 6 days of incubation (Fig. 2a) . Apigenin also significantly stimulated hemoglobins a, b, and c production following 8 days of treatment (Fig. 2b) . Results of glycophorin A expression assay as well as the observed effect on K562 cell morphology (Fig. 3a) revealed similar differentiation induction abilities of these two compounds (Fig 3b   and c) . Treatment with 50 lM apigenin, a lower concentration than apigetrin (75 lM), had the same level of glycophorin A expression which is not surprising as it has been proven that glycosylation can result in a drastic decrease in a flavonoid's activities [2] . The absence of glycoside in apigenin's structure most likely contributed to its effectiveness at a lower concentration.
The ability of flavones, 7-hydroxyflavone, luteolin and chrysin, and one flavanone, naringenin, to induce erythrocyte differentiation in chronic myeloid leukemia K562 cells was also determined. Luteolin has been intensively studied during the last decades for its effect against several cancers such as colon cancer, prostate cancer, and lung cancer [26] [27] [28] , and it has been shown that its anticancer activity was through potentiation of both apoptotic pathways and suppression of cell survival pathways. The extrinsic apoptosis pathway is mediated by death receptors (TNFR1/Fas/DR4/DR5), resulting in sequential activation of initiator caspase 8 and executor caspases 3 and 7. The intrinsic apoptosis pathway on the other hand, is initiated by lose of mitochondrial potential [29] . Chrysin also inhibit the growth of different cancer cells such as cervical cancer, esophageal squamous carcinoma, breast cancer, malignant glioma, prostate cancer, and colon cancer by induction of the apoptotic pathways in leukemia cells in U937 human promonocytic cells, in megakaryoblastic leukemic cell line MO7e, as well as cause mitochondrial dysfunction in THP-1 and HL-60 leukemia cells [30, 31] . The anticancer activity of naringenin in different cancer cell lines as well as in leukemia cell lines U937, THP-1, and K562, has also been shown to be through the apoptotic pathways [32] [33] [34] . Based on studies on the therapeutic effect of flavonoids on cancer, the induction of apoptosis is a common pathway by flavonoids to treat cancers, especially hematological cancers [35] . There are already reports on the differentiation of leukemic cells to specific types of blood cells after treatment with dietary flavonoids [36] [37] [38] comparing the different flavonoids' differentiationinducing effect on leukemia cells [13, 39, 40] but did not identify the specific functional group in apigenin's structure responsible for the observed differentiation induction effect on K562 cells. The flavonoids used in this study, except for naringenin, inhibited K562 cell proliferation in a dose-dependent manner (Fig. 5a ). In a related study using leukocytes, Kanno et al. (2005) reported that the EC50 of naringenin is 153 ± 15 lM [32] . In this study, the flavonoids decreased the growth rate of K562 cells without significantly decreasing the cell viability (80-100%) (Fig. 5b) . K562 cells are multipotential, hematopoietic malignant cells that could differentiate into recognizable progenitors of the erythrocyte, granulocyte, monocyte, and megakaryocyte lineages. K562 cells treated with apigenin, chrysin, flavones, and 7-hydroxyflavone differentiated into erythrocytes. In contrast, luteolin and naringenin appeared to have no erythroid differentiation-inducing effect (Fig. 7) . These results support findings of studies that demonstrated that apigenin exerts a broad range of molecular signaling effects in cancer cells, one of the main target of which is the cell cycle. Apigenin modulates the cell cycle distribution in various malignant cells and induces the arrest at G2/M and G0/G1 phases by inhibiting the p34 (cdc2) kinase activity or up-regulating the expression of p21 [41] . In leukemia cells, apigenin block the cell cycle progression at G2/M phase in HL-60 cells, K562 cells and in human acute lymphoblastic leukemia MT-4 cells and at G0/G1 phase in erythroid TF1 cells [14, 15, 42, 43] . It is believed that cell cycle arrest is a prerequisite for hematopoietic cell differentiation, even though the precise mechanisms between cell cycle and differentiation remain unclear. Thus, G2/M arrest of K562 cells by apigenin treatment enabled the cells to undergo erythrocyte differentiation [15] . Another possible explanation for the cytotoxicity of apigenin on leukemia cell lines is through the induction of autophagy. Ruelade-Sousa et al. (2009) showed that a block in cell cycle induces autophagy in the HL-60 and TF1 cell lines [42] . Inhibition of autophagy was observed to enhance apoptosis in apigenin-treated human breast cancer cells [44] . In this study however, the data obtained clearly showed that apigenin induced cell differentiation in K562 cells. Microscope observations also ruled out autophagy (data not shown).
The expressions of fetal hemoglobin components -a-hemoglobin, b-hemoglobin, c-hemoglobin mRNA can validate erythroid differentiation. Real-time PCR results showed that a and c hemoglobin expressions were highest in apigenin-treated cells, followed by the chrysin. As expected, globin genes were not expressed in significant levels in luteolin-and naringenin-treated cells (Fig. 8) . The hemoglobin molecule is a tetramer composed of 2 heterodimers. After the embryonic stages and up to 2 years old in human, the fetal hemoglobin, is composed of 2 chains of a-globin and 2 chains of c-globin (a2 c2). The adult form of hemoglobin, on the other hand, is composed of 2 chains of a-globin and 2 chains of b-globin (a2 b2). Fetal hemoglobin is present in low concentrations in the mature red blood cells in healthy adults [45] . Our results showed that apigenin increased the expression of a and c hemoglobin genes in K562 cells. Increased fetal hemoglobin production is considered an important alternative for the treatment of b-thalassemia, a hematological disease caused by mutations in the b-globin gene. Thus, the synthesis of fetal hemoglobin could compensate for the shortfall of adult hemoglobin synthesis in b-thalassemia patients [46] . The c-globin gene is one of the 5 globin genes located in the b-globin locus, which are respectively, beta (b)globin gene, delta (d),gamma-A (Ac), gamma-G (Gc), and epsilon (e)globin.
The flavones apigenin, chrysin, and luteolin, and the flavanone naringenin have similar structures (Fig. 4) , with the unsaturated C ring between C-2 and C-3 as the main difference between these two groups of flavonoids. The double bond between C2 and C3 is essential for higher biological activity such as in antioxidant, anti-inflammatory and anticancer activities [2, 17, 48, 49] . Kawaii et al. (1999) also highlighted the important role of the C2-C3 double bond in monocyte/macrophage differentiation of HL-60 cells by citrus flavonoids [39] . In another study, apigenin and luteolin, but not naringenin, induced the granulocytic differentiation of myeloid leukemia cells [15] and this was attributed to the higher volume/ surface ratio of the molecules of flavones compared to the flavanones [2] . Furthermore, C2-C3 double bond contributes to the planar aspect of the molecule, while its absence makes the phenyl group (B ring) nearly perpendicular to the rest of the molecule giving a bigger volume/surface ratio. Additionally, apigenin, chrysin, flavone, 7-hydroxyflavone, and luteolin are structurally different flavones owing to the number and the position of the hydroxyl groups in their structures, with luteolin having the highest number of hydroxyl groups, followed by apigenin, chrysin, 7-hydroxyflavone and finally flavone, which does not have any hydroxyl in its chemical structure (Fig. 4) . The number of hydroxyl group (-OH) and their position in the flavonoid's skeleton are two of the contributing factors for their bioactivities [19] . For instance, more hydroxyl groups lead to better ROS-scavenging and anti-cancer activity [50] , and the most active compounds are those having hydroxyl groups at C4 0 and/or C3 0 [47] . Wang et al. (2012) indicate that pro-anthocyanidins from antioxidant grape seeds are likely to induce monocytic differentiation in K562 cells, mostly through decreasing iROS formation and inducing phase G1 arrest [51] . In this study, results indicate that apigenin had greater erythroid differentiation effect on K562 cells than chrysin that lacks the 4 0 -OH groups). We suggest that the anti-oxidant activity of apigenin is due to the free hydroxyl group at the C-4 0 position that enhanced its erythroid differentiation ability. On the other hand, luteolin (with 3 0 4 0 -OH groups) was apparently still not as effective as differentiation inducer compared to apigenin. Matsuo et al. (2005) , studied the cytotoxicity (LD 50 ) of nine flavonoids toward two types of normal human cells [52] and found that luteolin was the most toxic toward human umbilical vein endothelial cells compared to other flavonoids even though flavonoids cytotoxicity has been shown to be dependent on the cell type. Here, the MTT and cell viability assay results showed that among the six flavonoids, luteolin-treated K652 cells had the lowest cell proliferation rate (Fig. 5a) , and did not undergo cell differentiation based on the glycophorin A and the hemoglobin genes expressions (Figs. 7 and 8 ).
Conclusions
Here, we have shown that the flavonoids representing the functional groups in the apigenin structure had differentiation-induction effect on K562 cells. The effectiveness of these flavonoids in the induction of erythroid cell differentiation, based on glycophorin A and hemoglobin genes expressions, may be ranked as: apigenin > chrysin > flavone/7-hydroxyflavone > luteolin/naringenin. These results suggest that the strong erythroid differentiation effect of apigenin on K562 cells was due to the presence of C2-C3 double bond and the hydroxyl groups. The hydroxyl groups most likely rendered apigenin effective for inducing cell differentiation but also probably made the other flavonoids cytotoxic as in the case of luteolin. This study provided the data for the relationship between the flavonoids structure and their cell differentiation induction effect and provides new information for the design of cancer chemopreventive agents for human leukemia.
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